To investigate whether knockdown of BCL9 and BCL2 counteracts the effects of miR‐140‐3p inhibition on CRC cells, HCT 116 cells were transfected with miR‐140‐3p inhibitor and siRNA of BCL9 or BCL2. The gene discussed is BCL9; the disease is colorectal carcinoma.